Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carole Ho currently holds 4,545 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carole Ho has been a net seller of DNLI stock. They have purchased $0 and sold $12.9M worth of shares.
Carole Ho's most recent insider trade was on Jun 5, 2026, when they sold 4,545 shares at $0.00 per share.
Carole Ho serves as Executive at Denali Therapeutics Inc. (DNLI). They have executed 166 insider transactions totaling $12.9M over their tenure at the company.
Carole Ho holds the position of Executive at Denali Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Carole Ho has shown a selling trading pattern, with $0 in total purchases and $12.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Carole Ho was on Aug 21, 2024, when they sold $344.1K worth of DNLI shares. This transaction involved 14,098 shares at $24.41 per share.
Carole Ho currently owns 4,545 shares of Denali Therapeutics Inc. (DNLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carole Ho's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carole Ho has 166 Form 4 filings on record as an insider at Denali Therapeutics Inc..
Set alerts for Carole Ho and 40,000+ other insiders.